Search research articles
Contact Us
Filters
Showing results (61-70 of 146) with videos related to
Page
of 15
Sort By:
Cancer Immunology, Immunotherapy : CII
|
September 15, 2017
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression
Jonathan P O Hebb, Adriane R Mosley, Felipe Vences-Catalán, et al.
Plos One
|
July 9, 2010
Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma
Lauren E Woodard, Annahita Keravala, W Edward Jung, et al.
Science Translational Medicine
|
February 1, 2013
CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis
Bikul Das, Suely S Kashino, Ista Pulu, et al.
Oncotarget
|
November 5, 2017
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma
Candace J Poole, Wenli Zheng, Atul Lodh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 18, 2010
Noninvasive molecular imaging of c-Myc activation in living mice
Hua Fan-Minogue, Zhongwei Cao, Ramasamy Paulmurugan, et al.
Nature Chemistry
|
May 23, 2014
Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo
Deju Ye, Adam J Shuhendler, Lina Cui, et al.
Cancer Research
|
July 5, 2006
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species
Suma Ray, Kondala R Atkuri, Debabrita Deb-Basu, et al.
The Journal of Biological Chemistry
|
January 19, 2011
Reactive oxygen species regulate nucleostemin oligomerization and protein degradation
Min Huang, Patrick Whang, Jayanth V Chodaparambil, et al.
Cancer Research
|
January 26, 2011
MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase
Zhongwei Cao, Hua Fan-Minogue, David I Bellovin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2014
Alteration of the lipid profile in lymphomas induced by MYC overexpression
Livia S Eberlin, Meital Gabay, Alice C Fan, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 146) with videos related to
Sort By:
Page
of 15
Cancer Immunology, Immunotherapy : CII
|
September 15, 2017
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression
Jonathan P O Hebb, Adriane R Mosley, Felipe Vences-Catalán, et al.
Plos One
|
July 9, 2010
Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma
Lauren E Woodard, Annahita Keravala, W Edward Jung, et al.
Science Translational Medicine
|
February 1, 2013
CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis
Bikul Das, Suely S Kashino, Ista Pulu, et al.
Oncotarget
|
November 5, 2017
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma
Candace J Poole, Wenli Zheng, Atul Lodh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 18, 2010
Noninvasive molecular imaging of c-Myc activation in living mice
Hua Fan-Minogue, Zhongwei Cao, Ramasamy Paulmurugan, et al.
Nature Chemistry
|
May 23, 2014
Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo
Deju Ye, Adam J Shuhendler, Lina Cui, et al.
Cancer Research
|
July 5, 2006
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species
Suma Ray, Kondala R Atkuri, Debabrita Deb-Basu, et al.
The Journal of Biological Chemistry
|
January 19, 2011
Reactive oxygen species regulate nucleostemin oligomerization and protein degradation
Min Huang, Patrick Whang, Jayanth V Chodaparambil, et al.
Cancer Research
|
January 26, 2011
MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase
Zhongwei Cao, Hua Fan-Minogue, David I Bellovin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2014
Alteration of the lipid profile in lymphomas induced by MYC overexpression
Livia S Eberlin, Meital Gabay, Alice C Fan, et al.
Page
of 15